MetaCap

BioVie Insider Trades

NASDAQ: BIVIHealth CareBiotechnology: Pharmaceutical PreparationsUSD

1.39+0.11 (+8.59%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
4 · $49.12K
Sales
0 · $0
Shares bought / sold
23.28K / 0
Net activity
Net buying $49,118

BioVie insider activity

Over the last 12 months, BioVie insiders reported 4 transactions on SEC Form 4: 4 open-market purchases and 0 sales. Insiders bought $49,118 and sold $0 worth of stock, for net insider buying of $49,118. The most recent filing shows Chappell Amy Suzon (Director) buying 727 shares at $2.16 on Aug 28, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put BIVI's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

BIVI insider transactions

BioVie insider transactions
DateInsiderTypeSharesValueFiling
Aug 28, 2026KIM JOANNE WENDYChief Financial OfficerBuy2,500$5.45KForm 4
Aug 28, 2026Palumbo Joseph MChief Medical OfficerBuy4,843$10.46KForm 4
Aug 28, 2026Chappell Amy SuzonDirectorBuy727$1.57KForm 4
Aug 27, 2026DO CUONG VPresident & CEOBuy15,210$31.64KForm 4
Aug 7, 2025DO CUONG VPresident & CEOBuy5,000—Form 4
Nov 20, 2024ROGICH SIGMUNDDirectorAward32,700—Form 4
Nov 20, 2024BERMAN RICHARD JDirectorAward34,200—Form 4
Jun 24, 2024KIM JOANNE WENDYChief Financial OfficerTax withholding18,250$8.65KForm 4
Jun 24, 2024KIM JOANNE WENDYChief Financial OfficerAward73,000—Form 4
Jun 24, 2024Palumbo Joseph MChief Medical OfficerTax withholding29,000$13.75KForm 4
Jun 24, 2024Palumbo Joseph MChief Medical OfficerAward116,000—Form 4
Jun 24, 2024DO CUONG VPresident & CEOTax withholding42,000$19.91KForm 4
Jun 24, 2024DO CUONG VPresident & CEOAward168,000—Form 4
Mar 4, 2024DO CUONG VPresident & CEOBuy10,000—Form 4
Feb 15, 2024KIM JOANNE WENDYChief Financial OfficerTax withholding2,476$2.92KForm 4
Feb 15, 2024Palumbo Joseph MChief Medical OfficerTax withholding2,476$2.92KForm 4
Feb 15, 2024DO CUONG VPresident & CEOTax withholding4,953$5.84KForm 4
Dec 11, 2023KIM JOANNE WENDYChief Financial OfficerAward5,000—Form 4
Dec 1, 2023GORLIN STEVEDirectorSale75,680$127.90KForm 4
Nov 30, 2023DO CUONG VPresident & CEOBuy10,000$17.80KForm 4
Nov 9, 2023BERMAN RICHARD JDirectorAward51,830—Form 4
Nov 9, 2023Hariri Robert JDirectorAward42,254—Form 4
Nov 9, 2023ROGICH SIGMUNDDirectorAward42,254—Form 4
Nov 9, 2023GORLIN STEVEDirectorAward46,358—Form 4
Sep 5, 2023GORLIN STEVEDirectorSale8,560$26.11KForm 4
Aug 22, 2023BERMAN RICHARD JDirectorSale10,805$37.83KForm 4
Jun 29, 2023DO CUONG VCEO & PresidentAward149,500—Form 4
Jun 21, 2023DO CUONG VCEO & PresidentOption exercise41,506—Form 4
Jun 7, 2023BERMAN RICHARD JDirectorSale5,984$34.78KForm 4
May 22, 2023BERMAN RICHARD JDirectorSale5,000$32.51KForm 4
Feb 16, 2023KIM JOANNE WENDYChief Financial OfficerTax withholding2,476$13.64KForm 4
Feb 16, 2023Palumbo Joseph MChief Medical OfficerTax withholding2,476$13.64KForm 4
Feb 16, 2023DO CUONG VPresident & CEOTax withholding4,953$27.29KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related